Filters

Constance Delaugerre, Isabelle Charreau, Josephine Braun, Marie-Laure Néré, Nathalie de Castro, Patrick Yeni, Jade Ghosn, Jean-Pierre Aboulker, Jean-Michel Molina, François Simon

AIDS (London, England) 2011;24(15):2391-5

Full Text

Abstract

Impact of subtype C-specific amino acid variants on HIV-1 Tat-TAR interaction: insights from molecular modelling and dynamics.

Keaghan Brown, Piwai T Gotora, Monray E Williams, Ruben Cloete, Rencia van der Sluis, Darius R Martin

Virology journal 2024;21(1):144

Free Full Text

Abstract

Immunophenotype of vitamin D receptor polymorphism associated to risk of HIV-1 infection and rate of disease progression.

Carmen Torres, Manuel Sánchez de la Torre, Carelia García-Moruja, Antonio José Carrero, María del Monte Trujillo, Joan Fibla, Antonio Caruz

Current HIV research 2011;8(6):487-92

Full Text

Abstract

Regulating eukaryotic gene expression with aptamers.

Jean-Jacques Toulmé, Carmelo Di Primo, David Boucard

FEBS letters 2004;567(1):55-62

Free Full Text

Abstract

Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification.

Rutao Luo, E Fabian Cardozo, Michael J Piovoso, Ryan Zurakowski

Journal of theoretical biology 2014;345():61-9

Free Full Text

Abstract

No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy.

Rajesh T Gandhi, Robert W Coombs, Ellen S Chan, Ronald J Bosch, Lu Zheng, David M Margolis, Sarah Read, Beatrice Kallungal, Ming Chang, Erin A Goecker, Ann Wiegand, Mary Kearney, Jeffrey M Jacobson, Richard D'Aquila, Michael M Lederman, John W Mellors, Joseph J Eron

Journal of acquired immune deficiency syndromes (1999) 2012;59(3):229-35

Free Full Text

Abstract

Influence of generation 2-5 of PAMAM dendrimer on the inhibition of Tat peptide/ TAR RNA binding in HIV-1 transcription.

Wei Wang, Zhenpeng Guo, Yi Chen, Tao Liu, Long Jiang

Chemical biology & drug design 2007;68(6):314-8

Full Text

Abstract

Results: 1 – 15 / 25

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""HIV Long Terminal Repeat""[mesh_terms]

HIV-1 Tat amino acid residues that influence Tat-TAR binding affinity: a scoping review.

Mg2+-induced variations in the conformation and dynamics of HIV-1 TAR RNA probed using NMR residual dipolar couplings.

HIV-1 integrase inhibitors: past, present, and future.

OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions.

Arginine Forks Are a Widespread Motif to Recognize Phosphate Backbones and Guanine Nucleobases in the RNA Major Groove.

Curcumin and its analogues: a potential natural compound against HIV infection and AIDS.

Kinetic characterization of TAR RNA-Tat peptide and neomycin interactions by acoustic wave biosensor.

Revealing hidden protonated conformational states in RNA dynamic ensembles.

Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen.

Impact of subtype C-specific amino acid variants on HIV-1 Tat-TAR interaction: insights from molecular modelling and dynamics.

Immunophenotype of vitamin D receptor polymorphism associated to risk of HIV-1 infection and rate of disease progression.

Regulating eukaryotic gene expression with aptamers.

Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification.

No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy.

Influence of generation 2-5 of PAMAM dendrimer on the inhibition of Tat peptide/ TAR RNA binding in HIV-1 transcription.

Results for
""HIV Long Terminal Repeat""[mesh_terms]